 |
 Video: Compound Annual Growth Rate (CAGR) Definition
|
|
| Date |
Open |
High |
Low |
Close |
Volume |
| 01/16/2025 |
$3.21 |
$3.21 |
$2.98 |
$3.03 |
599.70K | | 01/17/2025 |
$3.06 |
$3.10 |
$2.95 |
$3.00 |
576.20K | | 01/21/2025 |
$2.99 |
$3.03 |
$2.91 |
$3.00 |
584.80K | | 01/22/2025 |
$3.03 |
$3.12 |
$3.01 |
$3.08 |
831.80K | | 01/23/2025 |
$3.08 |
$3.19 |
$3.06 |
$3.16 |
597.50K |
|
|
| MacroGenics, Inc. is a biopharmaceutical company focused on developing and commercializing monoclonal antibody-based therapeutics for the treatment of cancer. It generates its pipeline of product candidates primarily from its suite of antibody-based technology platforms, which have applicability across broad therapeutic domains. It is developing product candidates that target various tumor-associated antigens and immune checkpoint molecules. Its lead pipeline program is vobramitamab duocarmazine (vobra duo), an antibody-drug conjugate (ADC) that targets B7-H3, a molecule in the B7 family of immune regulator proteins that is expressed by several different tumor types. | |
|
MacroGenics (MGNX) has the following price history information. Looking back at MGNX historical stock prices for the last five trading days, on January 16, 2025, MGNX opened at $3.21, traded as high as $3.21 and as low as $2.98, and closed at $3.03. Trading volume was a total of 599.70K shares. On January 17, 2025, MGNX opened at $3.06, traded as high as $3.10 and as low as $2.95, and closed at $3.00. Trading volume was a total of 576.20K shares. On January 21, 2025, MGNX opened at $2.99, traded as high as $3.03 and as low as $2.91, and closed at $3.00. Trading volume was a total of 584.80K shares. On January 22, 2025, MGNX opened at $3.03, traded as high as $3.12 and as low as $3.01, and closed at $3.08. Trading volume was a total of 831.80K shares. On January 23, 2025, MGNX opened at $3.08, traded as high as $3.19 and as low as $3.06, and closed at $3.16. Trading volume was a total of 597.50K shares.
MGNX Historical Stock Prices By Date:
Below, we examine the compound annual growth rate — CAGR for short — of an investment into MacroGenics shares, starting with a $10,000 purchase of MGNX, and working forward through the historical stock price information to today.
Growth of $10,000.00
Without Dividends Reinvested
|
| Start date: |
01/27/2015 |
|
| End date: |
01/23/2025 |
|
| Start price/share: |
$32.74 |
|
| End price/share: |
$3.16 |
|
| Dividends collected/share: |
$0.00 |
|
| Total return: |
-90.35% |
|
| Average Annual Total Return: |
-20.85% |
|
| Starting investment: |
$10,000.00 |
|
| Ending investment: |
$965.58 |
|
| Years: |
10.00 |
|
|
|
| Date |
Close |
| 01/16/2025 | $3.03 | | 01/17/2025 | $3.00 | | 01/21/2025 | $3.00 | | 01/22/2025 | $3.08 | | 01/23/2025 | $3.16 |
|
|
Free MGNX Email Alerts:
